CK

Chandra Kanta Das

Active Director Director DIN 08005431
DIN 08005431 First appointment Feb 2018 Primary industry Research & Development
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value •••• Premium profile

About Chandra Kanta Das

Data last updated:

Chandra Kanta Das is a Director at Euphony Clinical Research Private Limited (since 2018). The company operates in Research & Development. Euphony Clinical Research Private Limited reported revenue of ₹2.3 Lakh (FY 2022).

DIN 08005431
Primary Designation Director
Industry Research & Development
First Appointment 02 Feb 2018
Oldest Company Age 8 yrs
Largest company Euphony Clinical Research Private Limited · ₹2.3 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Feb 20182018₹2.3 Lakh (FY 2022)Active

Board colleagues of Chandra Kanta Das

Directorship timeline

Open interactive timeline →
Euphony Clinical Research Private Limited
Premium access

Shareholding and investment profile for Chandra Kanta Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandra Kanta Das

Chandra Kanta Das currently holds 1 directorship: Euphony Clinical Research Private Limited (Director, since 02 Feb 2018, revenue ₹2.3 Lakh (FY 2022)).

Chandra Kanta Das was first appointed on 02 Feb 2018 as Director at Euphony Clinical Research Private Limited.

The current boards of Chandra Kanta Das's companies include Padalia Avniben Chhaganbhai (Euphony Clinical Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available